Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy
Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the efficacy of interferon beta and thalidomide in male patients with
adrenoleukodystrophy who show evidence of brain inflammatory response and are receiving
concurrent glyceryl trierucate and glyceryl trioleate (Lorenzo's oil).
II. Evaluate the progress of the disease and possible side effects of the medication in these
patients.
Phase:
N/A
Details
Lead Sponsor:
FDA Office of Orphan Products Development
Collaborator:
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.